Actualités sur Health

08.03.2012 – 08:11
Shire Pharmaceuticals Group Plc
More Choice for CKD Patients in Europe as FOSRENOL® is Approved in a New Oral Powder Formulation
Nyon, Switzerland (ots/PRNewswire) - Shire plc , the global specialty biopharmaceutical company, today announced it has received approval through the European Decentralised Procedure for an oral powder formulation of FOSRENOL (lanthanum carbonate). FOSRENOL is a non-calcium, non-resin phosphate binder indicated as a phosphate binding agent for use in the control of ...
plus
01.03.2012 – 10:03
Hitachi Medical Systems Europe Holding AG
ECR 2012: Hitachi Medical Systems Europe Holding AG to present its new, combined Hitachi Aloka ultrasound portfolio and a new era in MR imaging
Zug, Switzerland (ots) - - - First ECR presentation of the combined Hitachi and Aloka ultrasound portfolio with its many highlights - New upgrades for ProSound F75 - New ergonomic lightweight ultrasound system F37 - Image fusion with Hitachi Real-time Virtual Sonography - A new era in MR imaging: the Echelon Oval ...
plus
29.02.2012 – 13:01
E.S.PKU (European Society for Phenylketonuria and Allied Disorders Treated as Phenylketonuria)
E.S.PKU Urges Policy Makers to Close Significant Gaps in Care for Patients with Phenylketonuria (PKU) Across Europe at the European Parliament
Brussels (ots/PRNewswire) - - World Rare Disease Day 2012 Today, on World Rare Disease Day, the European Society for Phenylketonuria and Allied Disorders (E.S.PKU) urged policy makers to bridge significant gaps in Phenylketonuria (PKU[1]) care across Europe during a lunch debate at the European Parliament. The ...
plus
29.02.2012 – 06:59
LifeWatch AG
EANS-Adhoc: LifeWatch AG to report on promising Fourth Quarter 2011 and Full Fiscal Year 2011 Financial Results (with document)
http://resources.euroadhoc.com/us/FKLabGTF issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
Un document
plus
27.02.2012 – 02:02
Astellas European Foundation
The Astellas European Foundation Winner of Urology 2012 Grant Announced
Staines, England (ots/PRNewswire) - The Astellas European Foundation is delighted to announce the winner of the 2012 Urology Grant: Dr Gommert Van Koeveringe from Maastricht University Medical Center, the Netherlands The team including Dr Daisy Vrijens from Maastricht University and Professor Matthias Oelke from the University of Hannover, Germany received the grant of ...
plus
24.02.2012 – 08:56
Astellas Pharma Europe Limited
New Class of Treatment for Overactive Bladder Demonstrates Efficacy and Tolerability Across Three Separate Studies
Paris (ots/PRNewswire) - ASTELLAS PHARMA EUROPE Ltd., European subsidiary of Tokyo-based Astellas Pharma Inc. today announced results from three separate clinical trials that further support the efficacy and tolerability of mirabegron. Mirabegron, a beta3 adrenoceptor agonist, is the first in a new class of ...
plus
24.02.2012 – 06:57
LifeWatch AG
EANS-Adhoc: LifeWatch announces joint development of new breakthrough test for its wireless cardiac monitoring platform (with document)
http://resources.euroadhoc.com/us/9HSfZYNF issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
Un document
plus
22.02.2012 – 17:38
LifeWatch AG
EANS-Adhoc: LifeWatch AG to report on Fourth Quarter 2011 and Full Fiscal Year 2011 Results on February 29, 2012 (with document)
http://resources.euroadhoc.com/us/FXCyZ1yC http://resources.euroadhoc.com/us/zkFOkW65 issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: ...
2 Documents
plus
22.02.2012 – 12:50
BioGaia
Lactobacillus reuteri Protectis Reduced Diarrhoea in Children
Stockholm (ots/PRNewswire) - A double-blind, placebo-controlled study of 494 children showed that supplementation of Lactobacillus reuteri Protectis significantly reduced episodes of diarrhoea. Lactobacillus reuteri Protectis was particularly effective in children with lower nutritional status. Another probiotic strain, which was also tested, was without effect. Study design The six month long double-blind, ...
plus
16.02.2012 – 13:33
Ecole Polytechnique de Montreal
Nanosurgery and the Fight Against Cancer: Major Breakthrough at Polytechnique Montréal
Montreal (ots/PRNewswire) - Researchers at Polytechnique Montréal have succeeded in changing the genetic material of cancer cells using a brand-new transfection method. This major breakthrough in nanosurgery opens the door to new medical applications, among others for the treatment of cancers. A light scalpel to treat cancerous cells The unique method developed by ...
plus
02.02.2012 – 17:38
LifeWatch AG
EANS-Adhoc: LifeWatch AG to report on Fourth Quarter 2011 and Full Fiscal Year 2011 Results on February 29, 2012 (with document)
http://resources.euroadhoc.com/us/tUWWf6D1 http://resources.euroadhoc.com/us/tE5JR0Lk issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: ...
2 Documents
plus
02.02.2012 – 10:32
Canon Europe
Canon Europe Acquires Dutch Medical Solutions Specialist Delft DI
London (ots/PRNewswire) - Canon Europe, world-leader in imaging solutions, has strengthened its offering in the Medical Imaging arena by acquiring Netherlands-based Medical solutions specialist Delft Diagnostic Imaging (Delft DI). Delft DI specialises in two business areas. The first area is innovative medical software solutions for sharing digital images and medical ...
plus
31.01.2012 – 17:37
LifeWatch AG
EANS-Adhoc: LifeWatch announces total 2011 contracts for ACT and Home Sleep testing services. Additional 4 Million new covered lives in Q4 2011. (with document)
http://resources.euroadhoc.com/us/3Ho4PosY issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
Un document
plus
23.01.2012 – 17:27
SAATI
New Coalition Calls for More Effective Adult Immunisation Strategies During European Union's 2012 Year for Active Ageing and Solidarity Between Generations
Paris (ots/PRNewswire) - An expert group of European public health advocates and professionals has created a dedicated partnership entitled SAATI - Supporting Active Ageing Through Immunisation - to encourage comprehensive adult immunisation policies in order to reduce the incidence of vaccine-preventable diseases ...
plus
23.01.2012 – 11:00
Ziehm Imaging
Arizona Heart: Three advanced technology operating rooms with state-of-the art C-arm solutions / Leading hospital for heart and vascular disease opts for Ziehm Vision RFD for virtually unlimited imaging
Nuremberg (ots) - Arizona Heart, one of the area's leading hospitals for the diagnosis and treatment of heart and vascular disease, has opted for Ziehm digital flat-panel C-arms for its three advanced technology suites. The Ziehm Vision RFD hybrid edition delivers distortion-free, high-resolution images for ...
plus
18.01.2012 – 10:03
Takeda Pharmaceutical Company Limited
Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth
Osaka, Japan (ots/PRNewswire) - Takeda Pharmaceutical Company Limited announced today strategic measures to better align its global workforce and consolidate site operations in order to integrate legacy Nycomed operations, strengthen its presence in more than 70 countries, adapt to changing market conditions and maintain a focus on growth through innovation and ...
plus
17.01.2012 – 13:55
TRON - Translational Oncology at University Medical Center Mainz
First preclinical proof-of-concept of mutation-based individualized cancer vaccine / Deep sequencing of immunogenic mutations may pave way for customized immunotherapy
Mainz (ots) - The Institute of Translational Oncology (TRON) together with BioNTech AG today announced the publication of a joint paper in the international journal Cancer Research that describes a new path for individually tailored cancer therapy. An interdisciplinary team of genome scientists and immunologists led ...
plus
17.01.2012 – 11:45
Pevion Biotech AG
Pevion's therapeutic Candida vaccine generates functional B cell memory in all vaccinees
Ittigen, Switzerland (ots) - Pevion Biotech AG today announced further data from the ongoing clinical study of its therapeutic Candida vaccine PEV7, demonstrating the generation of specific and functional B cell memory in 100% of vaccinees. Furthermore, the results again confirm the capability of Pevion's second generation virosomal vaccine platform to induce strong ...
plus
16.01.2012 – 08:02
Daiichi Sankyo Europe GmbH
Pan-European Stroke Prevention in Atrial Fibrillation Registry - PREFER in AF - Enrols First Patient
Munich (ots/PRNewswire) - - For European Media Only -- Collection of real life data from 5,000 atrial fibrillation patients (AF) across seven countries will generate invaluable insights into one of Europe's leading causes of stroke(1,2) -- Daiichi Sankyo Europe GmbH today announced the enrolment of the first patient ...
plus
12.01.2012 – 08:02
Brainlab AG
Brainlab's ExacTrac® System Achieves Major Sales Milestone
Munich (ots/PRNewswire) - 500th worldwide sale highlights healthcare providers continued focus on improving care with frameless radiosurgery Today Brainlab announced the 500th sale of its ExacTrac(R) patient positioning system for frameless radiosurgery. The scale of uptake highlights physicians continued focus on adopting clinically proven systems for high-precision cancer treatments and their ongoing investment in ...
plus
10.01.2012 – 17:37
LifeWatch AG
EANS-Adhoc: LifeWatch and Blue Shield of California sign first ever comprehensive agreement for its monitoring services (with document)
http://resources.euroadhoc.com/us/NLkgQKzC issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
Un document
plus
05.01.2012 – 01:03
European Commission
European Commission Inspires Europeans to Achieve New Year Resolution: Quitting Smoking for Good
Brussels (ots/PRNewswire) - New Year Brings New Way of Tackling Smoking for Thousands 2012 looks set to be the best year yet as the European Commission offers new thinking and support to quit smoking with their innovative campaign "Ex-Smokers are Unstoppable". A New Year is a new start - and the European Commission ...
plus
23.12.2011 – 20:14
Ansell Healthcare nv
Ansell Limited Invests in Lakeland Industries, Inc.
Melbourne, Australia (ots/PRNewswire) - Pursuant to the filing of a Form 13D with the United States Securities and Exchange Commission, Ansell Limited (ANN.AX), a global leader in protection solutions, today announced it has made an investment in Lakeland Industries, Inc. Ansell has acquired 9.66% of the issued and outstanding shares of common stock of Lakeland Industries, Inc. . Lakeland manufactures and sells a ...
plus
15.12.2011 – 21:18
Brainlab AG
CORRECTION - Brainlab AG: World?s First Curve(TM) Image Guided Surgery System Now Operating in Germany
Munich (ots/PRNewswire) - In the news release, "World?s First Curve(TM) Image Guided Surgery System Now Operating in Germany" issued on 15 Dec 2011 09:12 GMT, by Brainlab AG over PR Newswire, we are advised by a representative of the company that some minor changes were required to be made within the first paragraph ...
plus
15.12.2011 – 10:15
Brainlab AG
World's First Curve(TM) Image Guided Surgery System Now Operating in Germany
Munich (ots/PRNewswire) - Highly advanced surgical navigation system to enable faster, more precise and safer surgery This week, university hospital Klinikum rechts der Isar in Munich, Germany, is the first hospital in the world to operate with Brainlab's Curve(TM) Image Guided Surgery system. The new technology is hoped to provide surgeons with the best possible ...
plus
14.12.2011 – 07:02
Cryo-Save AG
A New International Congress on Regenerative Medicine Held With Great Success by Cryo-Save in Bosnia
Zutphen, The Netherlands (ots/PRNewswire) - It is part of Cryo-Save's educational program deployment to increase the awareness of stem cells therapy and regenerative medicine amongst healthcare professionals. The Second international congress "Regenerative medicine - stem cells, genetic engineering and ...
plus
13.12.2011 – 17:38
LifeWatch AG
EANS-Adhoc: LifeWatch and Tracker to launch LifeTracker in Switzerland. LifeTracker Mobile phone including medical consultation service for target group 55+. (with document)
http://resources.euroadhoc.com/us/rmvkjJOh issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
Un document
plus
13.12.2011 – 08:02
Daiichi Sankyo Europe GmbH
Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery
Munich (ots/PRNewswire) - Pooled results of the STARS E-III and STARS J-V studies presented at the 2011 American Society of Hematology (ASH) Annual Meeting Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced the results of a pooled analysis showing that edoxaban*, a direct oral once-daily ...
plus
09.12.2011 – 07:00
Sequana Medical AG
NHS National Innovation Centre estimates Sequana Medical's ALFApump® System could save the NHS £50 million in ascites care annually
Zurich, Switzerland (ots) - NHS National Innovation Centre supports the cost effectiveness of Sequana Medical's ALFApump System Sequana Medical announced today the findings of an independent economic assessment of the ALFApump System commissioned by the National Innovation Centre, the NHS organization which supports ...
plus
08.12.2011 – 16:23
Takeda Pharmaceutical Company Limited
Takeda's Edarbi® (azilsartan medoxomil) Receives European Marketing Authorisation for the Treatment of Essential Hypertension
London and Osaka, Japan (ots/PRNewswire) - Takeda Pharmaceutical Company Limited (Takeda) today announced that the European Commission has granted marketing authorisation for Edarbi(R) (azilsartan medoxomil), a new once-daily angiotensin receptor blocker (ARB) (also known as angiotensin II receptor antagonist ...
plus

Précédent55565758596061626364Suivant